Immunome, Inc.
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoti…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Immunome, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Immunome, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Immunome, Inc..